Feb 24, 2021
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia
Sep 17, 2020
Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership
Aug 04, 2020
Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares Expires on August 10
Mar 16, 2020
NuProbe Announces Strategic Collaboration with QIAGEN, Completes Multiple CE IVD Product Registrations
Feb 20, 2018
BD Launches Circulating Cell-Free DNA Blood Collection Tube for Cancer and Non-Invasive Prenatal Testing Applications
Dec 15, 2017
QIAGEN and Oxford Immunotec Settle Patent Infringement Lawsuit
Nov 15, 2017
QIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-leading QIAGEN Clinical Insight Software
Oct 19, 2017
QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening
Oct 05, 2017
QIAGEN Launches Fourth-generation QuantiFERON®-TB Gold Plus in the U.S.
Jul 13, 2017
QIAGEN N.V. to Report Second Quarter and First Half of 2017 Results
Jun 22, 2017
French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test
Jun 08, 2017
QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval
Jun 06, 2017
QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform
Jun 03, 2017
QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies
Jun 03, 2017
Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies